ApprovalTrail

Approval · Notice of Compliance 4301 · 1996

ORELOX: Notice of Compliance 4301

Issued August 6, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4301
Date
August 6, 1996
Company
Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Antibiotic

Products in this notice

BrandDINStatus today
ORELOX02226847Cancelled Pre Market

Medicinal ingredients